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1. Introduction
The CAD (Computer-aided Diagnosis) systems have been experiencing an exponential
growth in the last decades. Since the mid-1980s of time consuming film digitization
on a limited number of cases to its present status on large FFDM (Full-Field Digital
Mammography) databases Giger et al. (2008). The current usage of CAD systems has brought
about the need for breast cancer detection and classification efficient mechanisms. The CAD
algorithm sensitivity and specificity are influenced directly by database characteristics such
as image size, lesion distribution, and location of the lesion, biopsy results, BI-RADS™
classification and consensus opinion Giger et al. (2008). The use of existing mammographic
databases such as DDSM (Digital Database for Screening Mammography) Heath et al.
(2001b) with female patients mainly from theMassachusetts General Hospital mammography
program with the statistics of 56.18% (whites), 30.34% (unknown races), 2.06% (asians), 4.12%
(blacks), 6.55% (spanish surnames), 0.75% (other races), to tune the CAD algorithms can
avoid time consuming and expensive achievement but on the other hand can bias the CAD
algorithm to a women population not reflected in the image database, therefore causing
a ripple effect in the results Heath et al. (2001a). In the current study, we developed
an unprecedented database, the MIDAS (Mammographic Image Database for Automated
Analysis) covering a sample of Brazilian women population - such sample is primarily based
on FFDM images and whereas the population are not divides by races but on the other hand
are formed by a Brazilian unique mixing of indian south american, africans and european
populations along with genetic informations. The initial database contains about 600 digital
mammograms including two images of each breast, associated patient information, masses,
architectural distortion, special cases, calcification, associated findings, breast composition,
BI-RADS™ categories and overall impression. The MIDASmammogram images are obtained
from the Janice Lamas Radiology Clinic.
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1.1 The Janice Lamas Radiology Clinic
The Janice Lamas Radiology Clinic is a image diagnosis clinic founded in 1993 that performs
mammography exams for diagnosis and screening, general ultrasound exams, biopsies and
bone densitometry exams. The medical director is Janice Magalhães Lamas, M.D., PhD. and
her clinical interests include all aspects of breast imaging and intervention including digital
mammography with the use of CAD systems, breast ultrasound and dedicated breast MRI
(Magnetic Resonance Imaging). Dr. Janice’s expertise is requested regularly to speak at
brazilian meetings dedicated to radiology. In addition to her speaking engagements, she has
developing scientific research in breast cancer area and bone mineral density evaluation, and
she has published numerous articles on breast imaging. The clinic is also certified by the
Brazilian College of Radiology and Image Diagnosis.
1.2 The MIDAS approach
Unlike the others well established mammographic databases, the MIDAS database approach
includes all mammogram images covering a sample of Brazilian women population, patient
genome sequences data, open source image processing algorithms available, open access and
open collaborative environment. The unique characteristic of containing mammographic
imagens covering the Brazilian women population associated with the genomic
sequences is a brand new inovation that enhances the scientific research and discovery.
The MIDAS database also welcomes existing and new open source image processing
algorithms that allow the tests and validation on the mammographic images. All scientists
worldwide can participate in the MIDAS database with new algorithms and tools in a open
and collaborative environment.
1.3 Motivation
The lack of a genuine brazilian mammographic database and the collaborative and open use
and test of new CAD tools are the main motivation for MIDAS project. The MIDAS database
is an innovative database that integrates phenotypes - the mammograms and increasingly
their respective genotypes, according to patient biopsy and subsequent genome sequencing.
Complex studies for mapping the effect of distinct genes and their results in the mammogram
image pattern will enable the discovery of unknown cancer genes and help to understand
their pathways of behavior. The BI-RADS™ assessment for all mammograms is an additive
factor that enables better algorithm tunning.
2. Mammography screening
Screening to control chronic-degenerative diseases and diseases of neoplastic nature can be
defined as an examination on asymptomatic women, carried out with the intent of classifying
them as likely or unlikely to develop the disease Morrison (1992). The goal of screening is to
define women with preclinical disease as positive and women without preclinical disease as
negative. The result from the screening - positive or negative definition - reflects the efficacy
of the test in showing the signs of preclinical disease as well as correct interpretation of the
findings. An error, i.e. a positive definition for someone without preclinical disease, or a
negative definition for someone with the condition, can result from either low test efficacy or
incorrect interpretationMorrison (1992) Barratt et al. (2005). In a screening test, thematter that
is under investigation is the capability to correctly distinguish between diseased and healthy
individuals. Thus, to be certain that the disease is really present or absent, it is frequently
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the case that elaborate, expensive or risky tests, such as biopsies, surgical exploration or
autopsy, must be carried out Fletcher et al. (1996). Estimation of diagnostic test validity in
relation to a standard is certified by knowing the proportions of right diagnoses (true positives
and true negatives) and wrong ones (false positives and false negatives) Pereira (2000b).
In relation to mammography, the level of logic validity is based on consensus and expert
opinions Basset et al. (1994) Fletcher & Elmore (2005), and evaluations of accuracy are based
on histopathological examination of the suspected lesion. The ability of mammography to
define women with preclinical diseases as positive is referred to as its sensitivity. If measured,
it is around 78 to 85%. The specificity of the test is its ability to define as negative women
who do not have the disease. If measured, it should be greater than 90% Morrison (1992).
The sensitivity of the screening test is a determining factor for disease control programs and
the specificity directly influences the costs and feasibility of the screening program Morrison
(1992) Fletcher et al. (1996) Basset et al. (1994). All mammograms must be categorized as one
of the alternatives below Basset et al. (1994):
• True Positive: when cancer is diagnosed within a one-year period after a biopsy is
recommended.
• True Negative: when no cancer is diagnosed up to one year after a normal mammogram is
reported.
• False Positive: when no cancer is diagnosed within a one-year period after an abnormal
mammogram from which a biopsy is recommended; and when there is a benign finding
in a biopsy within a one-year period after an abnormal mammogram Fletcher & Elmore
(2005).
• False Negative: when cancer is diagnosed within a one-year period after a normal
mammogram is reported.
• Positive Predictive Value: refers to diferent rates, depending on the definition of
false positive. Based on an abnormal screening examination: 5-10%. Based on a
recommendation for biopsy or surgery: 25-40%. Based on the result from biopsies carried
out at the clinic, from an abnormal mammogram or from another diagnostic procedure
carried out on the breast, after a negative mammogram Basset et al. (1994); Sickles et al.
(2002).
2.1 Prevalence and incidence
A program for early detection and treatment is applicable in the case of diseases that present
a preclinical phase that cannot be diagnosed but is detectable, and for which the treatment
must offer some advantage over late treatment. The proportion of the population that has a
detectable preclinical phase is the prevalence. Prevalence depends, primarily, on the incidence
rate of the condition, which, in turn, reflects the action of causal factors. Prevalence varies
with the length of the preclinical phase. The greater the duration is, greater the proportion of
affected women will be Pereira (1996) Fletcher &Wagner (1996). Finally, prevalence depends
on whether or not previous screenings have been carried out Morrison (1992). A screening
test with greater sensitivity can detect tumors at the beginning of this phase. Prevalence
represents the stock of cases, new and old, and usually expresses damage of a chronic nature
Fletcher &Wagner (1996), such as breast cancer. Incidence is recognized as the most important
measurement in epidemiology because it relates to the dynamics of occurrence of a certain
event, over a specific observation time Pereira (1996). For example, among asymptomatic
women with previous mammography examinations that showed no suspicious signs of
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malignancy, it informs how many of them present subclinical breast cancer. Incidence is one
of the determining factors of prevalence Fletcher & Wagner (1996). In reality, estimation of
both incidence and prevalence enables better knowledge of the situation and consequently
enables adequate orientation of actions, with regard to implementation of new programs.
Implementation of an early detection program for breast cancer by means of mammography
must be preceded by studies that can evaluate the existing situation. Thus, before the possible
beneficial impact onmortality of early detection of malignant but asymptomatic lesions can be
measured, it is important to ascertain the breast cancer rate amongwomenwho are apparently
healthy Warren-Burhenne (1996). In Brazil, there are few reportsmeasuring the distribution of
malignant lesions detected by mammography screening among asymptomatic women Koch
(1998) Lamas & Pereira (1998).
2.2 Factors related to detection of breast cancer
Several factors influence early detection through mammography or delayed diagnosis of
malignant lesions among apparently normal women. Among these are the biological behavior
of the tumor, the type of equipment used, the technical ability of those who produce
and interpret the mammograms, the time interval between subsequent screenings and the
existence of a quality control program at the clinic Koch (1998) Sickles (1995). Technological
advances and greater knowledge of breast radiology have made it possible to identify
breast lesions with suspected malignancy earlier on Haus et al. (1990) Taplin et al. (2004).
The biological behavior of the tumor, which is inherent to each type of neoplasia and the
relationships established with the human organism, is one of the factors that determine the
length of the subclinical phase and hence favors or hinders early detection Taplin et al. (2004).
Length bias The growth speed of the tumor is a crucial matter, since the likelihood of cancer
detection during the preclinical phase depends on the length of this phase. There is little
chance of detecting tumors with a short preclinical phase before they are manifested clinically.
On the other hand, tumors with preclinical phases that last for years are more likely to be
discovered through screening Morrison (1992). Studies have shown that the mean duration of
the preclinical phase of cases diagnosed through mammography screening tends to be longer
than the mean duration of the cases that are routinely identified through the appearance of
symptoms Warren-Burhenne (1996) and that tumors that grow slowly during the preclinical
phase have the same behavior when symptomatic. Thus, screening would tend to detect
tumors with good prognoses, as a result of the bias from the length of the preclinical phase,
regardless of how much time is gained through early detection or how much benefit comes
from early treatment Black & Ling (1990) Zelen (1976). Prevalence bias Breast cancer has
faster growth among young women and slower growth among older women. It can remain
in the subclinical phase for an indeterminate length of time Moskowitz (1986). Research has
indicated that older women, aged over 50 years, have a longer preclinical phase of the disease,
compared with women aged less than 50 years, in whom the biological behavior of the tumor
is more aggressive Baker (1982) Kopans (1995).
However, mammography examinations contribute towards elevation of the prevalence rate,
through indiscriminately detecting tumors with progressive growth and those that may
remain without clinical manifestation for indeterminate periods Morrison (1992). This
constitutes a distortion, known as prevalence bias, caused by excessive representation of
long-duration cases and can occur in cross-sectional studies Fletcher & Wagner (1996).
Although these distortions can contribute towards high prevalence of subclinical lesions,
these rates have not been shown to be statistically different at ages of under and over 50
years in Brazil, which seems to indicate that prevalence bias is not the only explanation for
246 Mammography – Recent Advances
www.intechopen.com
MIDAS – Mammographic Image Database for Automated Analysis 5
the measurement found, especially among younger women Lamas & Pereira (1998). These
results are consistent with some other studies that observed that there was no drastic change
in cancer rates from under to over the age of 50 years Kopans (1995). Since the duration
of subclinical disease is greater among older women, it is expected that there will be a
proportionally greater number of affected women over the age of 50 years, represented by the
prevalence rates. The data from Brazil do not show statistically significant differences in the
proportion of women with cancer at the subclinical phase, at an initial stage of development,
comparing women under and over 50 years of age (P = 0.52). These studies in Brazil indicate
that detection of a greater number of tumors with slow growth and good prognostics is
not, in this particular case, related to age Lamas (2000). By contributing towards a higher
detection rate for malignant tumors, mammography includes lesions of different biological
behavior with distinguishing between them: lesions with rapid growth and those with slow
development Liff et al. (1991). The latter may remain asymptomatic for an indeterminate
period of time Feuer & Wun (1992). Regarding the frequency of malignant lesions, there is
a consensus that the tumor prevalence rate among asymptomatic women is between six and
ten cases per thousandwomen screened usingmammography Warren-Burhenne & Burhenne
(1992) . Rates lower than this standard range indicate that mammography is adding little
to clinical examination of breasts, in which case there could be many false negatives. In
Brazil, the data indicate high rates, in relation to population-based studies Vizcaíno et al.
(1998) Thurfjell & Lindgren (1994). The measurements are similar to the rates observed by
some institutional studies in developed countries at the beginning of their early detection
programs Warren-Burhenne & Burhenne (1992) Maya et al. (2006). Proposals that are feasible
for the public healthcare system need to be drawn up from quantitative data on disease
frequency. Such knowledge provides information on the magnitude and importance of the
damage to health Pereira (1996). The decision on whether it is appropriate or not to begin
mammography screening as a secondary prevention strategy must be based on relevant
measurements of breast cancer frequency among asymptomatic women.
2.3 Limitation of epidemiological studies
The variation inmorbidity due to breast cancer, for which there are multiple causal factors and
some are still little known, limits epidemiological studies, even in populations with similar
characteristics, which may invalidate comparisons between studies Pereira (1996) Sickles
(1992). It has to be borne in mind, regarding the distribution of morbidity, that the disease
affects women who are less favored in socioeconomic terms. As also seen with infectious
diseases, chronic-degenerative diseases and especially the advanced stages of breast cancer
are a greater scourge among less favored individuals. In Brazil, breast cancer is diagnosed
at advanced stages: more than 70 % of the cases are found in stages II to VI, a situation
in which the chances of cure are much smaller Maya et al. (2006) . According to data from
the National Cancer Institute, the estimated risk is 50 cases of this disease for every 100,000
women, including asymptomatic and symptomatic patients. It is therefore important to have
public policies that establish nationwide strategies for diagnosing breast cancer, such as the
breast cancer information system (SISMAMA) that has been implemented since 2008, and
the Mammography Quality Program. There are still flaws in screening for breast cancer in
Brazil. SISMAMA has not yet been implemented in all public clinics, and the quality control
program is not available in all clinics. However, some important tools for implementing public
policy regarding breast cancer prevention have been developed within the Brazilian National
Health System (SUS) . Higher social classes are better informed about primary and secondary
prevention mechanisms, as well as having greater access to health services, which influences
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morbidity Pereira (1996). This unequal access is in addition to unequal quality at diagnostic
centers, which is another condition responsible for the distorted picture of morbidity.
Screening attracts people who are more conscious about healthcare, among whom the disease
tends to take a more favorable clinical course, regardless of the time gained through early
detection or the benefit of timely treatment. This might not have such an influence on
the results if all members of the population were screened. One important point that also
influences the measurement of prevalence is sample selection. Samples composed by women
who seek medical care or are referred to a clinic dedicated to mammography do not constitute
a random sample, but rather, attendance of the demand. One important point to be discussed
in investigations from which the aim is to extrapolate the results is the use of randomization
for selection of elements for a sample. Age, social levels and ethnic characteristics are factors
associated with diseases, and thus, comparisons between groups with different characteristics
will be biased. Differences relating to sample selection The institutional nature of some
studies may introduce distortions and be responsible for differences in rates, because they
constitute attendance of the demand. To minimize this sample selection bias, one option is
to use women who undergo mammography examinations as periodic routine examinations
required by the companies in which they work. The higher breast cancer prevalence rate at
clinics that attend to the demand Sickles (1995) is explained by the greater incidence of the
disease in such groups, which expresses the presence of causal factors Kopans (1995) Lopes
et al. (1996). There is evidence that women exposed to a greater number of risk factors more
frequently seek specialized clinics, which explains some of the differences in the frequencies of
breast cancer between populations Smith (1993) Colditz et al. (1993). Women from privileged
economic classes are exposed to a greater number of risk situations, such as stress, lack
of breastfeeding, use of hormones, nulliparity and use of oral contraceptives, as well as
other factors that are associated with greater risk of developing other diseases, including
diets rich in animal fat and alcohol, among other factors Koch (1998) MacPherson et al.
(1983). These conditions are associated with greater risk of having breast cancer, and personal
antecedents of this neoplasia are the factor most strongly related to the disease Roubidoux
et al. (1997). Atypical hyperplasia, also known as a high-risk type of lesion, is similarly
strongly associated, and it has been estimated that the risk of developing in situ carcinoma
or subsequent invasive carcinoma is five to ten times greater Dupont et al. (1993) Boecker
et al. (2002). To affirm the causal relationship between the two events, it is necessary to
rule out alternative explanations, in order to avoid erroneous conclusions. Confounding
factors are one of these explanations, and therefore should be a matter of constant concern
during the development of a study: in its planning, in the statistical analysis and in the
interpretation of the results Pereira (1996). Differences relating to the existence of previous
screenings Another factor that influences the results is the absence of previous screenings. In
Brazil, unlike what is found in developed countries, there is no early detection program on a
national scale, and only recently has there been any encouragement for asymptomatic women
to undergo periodic mammography examinations, as a form of secondary prevention. This
explains the small percentage of womenwho had already undergone screening in the samples
of studies published on this issue. The yield from a screening test decreases proportionally
as it is repeated among a given group of people Chamberlain (1984). Prevalence studies
may differ in relation to the proportion of the women in the sample who had already
undergone mammography examinations, since the prevalence measurement includes both
new and old cases. The length bias that was described by some English authors Smith
(1995) Fletcher & Wagner (1996) may contribute to the high cancer rate found in samples
composed predominantly by older women, a situation in which the tumor presents slow
growth. Length bias is greater among the cases detected through the initial screening, a
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situation in which the prevalence of the tumors in this phase is predominantly represented by
lesions that have long preclinical phases. As the control examinations are repeated, especially
at short intervals, the distribution of the preclinical phase duration among the detected
subclinical cases becomes more similar to the distribution routinely diagnosed in a population
that did not undergo screening. In these circumstances, it could be that the length bias is less
important in the selection of the prognostic factors. However, if the preclinical phase of the
disease is short, continuous screenings would be necessary to reach the objective of detecting
lesions at these stages Morrison (1992). Differences relating to the measurement procedures
Methodological errors can give false interpretations to the results. Although the possibility is
smaller, the prevalence rate may be altered by distortions introduced into the measurement of
the procedures. Thus, in frequency investigations, these measurement biases appear when the
findings obtained from the sample data differ from those of the population, simply through
measurement problems. These deviations can occur when the event lacks definition, when
poorly elaborated questionnaires are used, when uncalibrated low-resolution equipment is
used, and when several data-gatherers, interviewers or observers are used, among other
situations Pereira (2000a) Sickles et al. (2002). Randomized clinical trials are considered to be
the standard of excellence, because they produce direct and unequivocal evidence to explain
a cause-effect relationship between two events Pereira (1996).
2.4 Comparative efficacy of self-examination, clinical breast examination and
mammography in screening for breast cancer
There is no way to separate the effects of mammography and clinical breast examination in
relation to reduction of mortality. Even with technological advances, there are no reasons to
suppose that a mammography screening program, in isolation from a clinical examination,
would have the same effect as when they are combined. Since the time of the first randomized
study, which began in 1960, a time at which the equipment used had low resolution,
mammography has been shown to be 1.6 times more sensitive than the examination carried
out separately, for mammography screening Baker (1982). It is important to emphasize that
clinical examination has been recommended as an early detection method for breast cancer .
Clinical breast examination is important for ruling out clinically evident tumors that do
not have a corresponding mammographic configuration. Although mammography is more
sensitive than clinical breast examination, 9% of tumors are only detected through palpation
Baker (1982). Nevertheless, with the technological evolution of mammography equipment,
some studies have observed a decrease in the rate of negative mammograms among patients
with palpable nodules . In these cases, non-visualization of the tumor throughmammography
may result from a variety of factors, but in most cases is a consequence of increased breast
density Tabár (1993) Kopans et al. (1996) Fitzgerald (2001). There is evidence that clinical
breast examination contributes towards the screening of suspected lesions Baker (1982) Miller
et al. (1992) Chu & Connor (1991). However, on a larger scale, it does not have an impact
relating to decreased risk of mortality due to cancer Humphrey et al. (2002).
3. Database image and data aquisition
All images are generated in DICOM format by digital mammography equipments at Janice
Lamas Radiology Clinic. At first moment the MIDAS database is available to general public
containing about 100 mammograms and 600 images and an image sample is shown in
Figure 1. The high definition images are available under personal request, after MIDAS
team approval. The low definition images are freely available to the general public. All
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Fig. 1. A Reduced Example of MIDAS Dicom Image
the genomic information will be extracted after breasts biopsies and genomic sequencing at
Genome Analyser Illumina GAIIx. All the images are obtained from the following equipment:
• Equipment: Mammomat Inspiration
• Voltage: 23 Kv to 35 Kv
• Large focus: 0.3 mm and small focus: 0.15 mm
• Pixel size: 85 µm and 70 µm
• Samples per pixel: 1
• Image size 2082 x 2800
• Bits allocated: 16
• Photometric interpretation: monochrome-1
The DBMS open source object-relational database system PostgreSQL is used to receive the
MIDAS database. The database conceptual modeling is presented in Figure 2.
4. Software tools
We provide a Web application (Midas-Web) for getting access to the database content and
for manipulating the database’ images through several digital image processing algorithms.
Therefore, at a high-level point of view, Midas-Web is both an information system (with
CRUD1 operations for the mammography database) as well as an extensible environment for
1 In the software community, CRUD operations correspond to basic functions that allow users to create,
update, delete, and query data base content
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Fig. 2. MIDAS Database Conceptual Model
playing with and experimenting digital image processing algorithms. Some goals have been
used to guide the design and development of Midas-Web:
• Basic mechanisms for authentication and authorization.
• Rapid application development cycle
• Extensible set of algorithms for digital image processing and interpretation
We realize three main usage profiles within the Midas-Web context. First, medical
practitioners might access Midas-Web to compare, through analogy, their diagnosis with
existing BI-RADS™ diagnosis present in the Midas database. Such a comparison is useful
for the purpose of increasing diagnosis’ confidence and teaching. Another usage profile
also corresponds to medical practitioners who want to share their findings, introducing new
cases in the Midas database. This usage profile is restricted by security policies, and Midas
administrators analyze all requests related to the introduction of new cases before making
them publicly available. Another usage profile correspond to researchers that want to apply
their algorithms for digital image processing and interpretation using the Midas database
images.
In the remaining of this section we detail some design decisions related to the Midas-Web
architecture, database schema and extensibility support for introducing new algorithms for
digital image processing.
4.1 Architecture
Midas-Web follows a standard web based architecture, in which the system is decomposed in
three principal layers Fowler (2002): the web layer, the business logic layer and the data source
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layer. The web layer provides the presentation logic, processing the user requests, calling
business operations, and forwarding to a proper graphical user interface (GUI) component that
should render the results of a user request.
The business logic layer is responsible for implementing the application transactional logic,
which usually involves algorithms for data validation and calculation. Actually, in the case of
Midas-Web, this layer is really thin, once Midas-Web basically provides CRUD operations to
the Midas database. Nevertheless, it is still important to consider this layer in the architecture,
since it increases the opportunities for code reuse.
Finally, the data source layer provides an abstraction over the underlying Midas database
system. Therefore, components in this layer implement services for accessing the database, in
such a way that we are able to evolve the database (for instance from a SQL based to a non
SQL database) without breaking the upper layers of the Midas-Web application.
Figure 3 presents the logical view of the Midas-Web architecture. In order to reduce the
development cycle, and also motivated by the low complexity of the business logic, we
developed Midas-Web using Grails Smith & Ledbrook (2009). Grails (or Groovy on Rails)
is a web development framework focused on productivity gains through the confluence of
the Groovy dynamic language Koenig et al. (2007) and the prevalence of source code structure
convention over configuration through XML files. The main components of a Grails application
are: (a) the Controller Classes, which handle user inputs and forward business’ responses to
suitable views; (b) The Grails Server Pages, which renders the graphical user interface; (c)
the Service Classes, which implements the business logic; and (d) the Domain Classes, which
describe the domain concepts and implement the data access layer to perform queries and
updates into the database.
Fig. 3. Logical view of the Midas-Web architecture
Grails offers a powerful integration with the Java language, so that it is possible to call existing
Java code from Grails, as well as Grails applications are package as a standard Java Web
Archive (WAR) and, as such, they could be deployed into Java Application Servers (like Tom
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Cat or JBOSS). The Java integration is useful because it supports the extensible architecture
for digital image processing, one of the contributions of Midas-Web (Section 4.3).
4.2 Database structure
The Midas database schema was influenced, at a great extent, by the BI-RADS™
classification D’Osri et al. (2003). For this reason, each patient, whose identity must
be preserved, might be associated with different studies (representing clinical cases or
investigations); and each study has properties such as:
• breast composition
• histology
• date in which the exam was conducted
• the main findings of the exam
In addition, and also according to the BI-RADS™ classification, each study must provide a
lesion description and at least four images (mammograms). Table 1 shows the attributes used
to describe a lesion, whereas Figure 4 presents part of the Midas database schema.
Attribute Domain
Assessment Negative
Benign Finding
Probably Benign Finding
Suspicious Abnormality
Highly Suggestive of Malignancy
Mass Shape Round
Oval
Lobulated
Irregular
Architectural distortion
Mass Margins Circumscribed
Microlobulated
Obscured
Ill Defined
Spiculated
Calcification Type Punctate
Amorphous
Pleomorphic
Round and Regular
Luscent Center
Fine Linear Branching
Calcification Distribution Clustered
Linear
Segmental
Regional
Diffuse
Table 1. Attributes of a lesion description according to BI-RADS™
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Fig. 4. Core relations of the Midas database schema
4.3 Extensibility support and collaborative environment
The MIDAS project group is a collaborative effort between Instituto Federal de Brasília,
University of Brasília Computer Science Department, University of Brasília Post-Graduate
Program in Biomedical Engineering, Catholic University of Brasília Post-Graduate Program
in Knowledge Management and Information Technology and Janice Lamas Radiology
Clinic. The MIDAS open and collaborative environment allows the users and developers to
participate in the research process. After MIDAS team validating all new image processing
algorithms, artifical intelligence tools, pattern recognition tools, and new findings can be
added to MIDAS database.
5. Assessment and automated analysis
5.1 MIDAS assessment
The MIDAS database and application has been tested during the startup process and along
its business life. The Information Technology infrastructure provided to MIDAS includes a
Cyber Data Center host service and hardware usage monitoring. All the image processing
algorithms and pattern recognition tools has been tested by Janice Lamas Radiology Clinic
experts and reports will be generated in order to improve the software tools.
5.2 Automated analysis: Breast cancer image assessment using an adaptive
network-based fuzzy inference system
The MIDAS database provides an ANFIS model algorithm Fernandes et al. (2010) for
automated analysis through every 600 mammogram images. This algorithm presents
an ANFIS model for a CAD (Computer Aided Diagnosis) prototype system to classify
calcifications in mammograms, in order to aid the medical expert in breast cancer diagnosis.
The proposedmodel embodies pre processing, detection, features extraction and classification
phases, which proved adequate for the study domain, obtaining similar results to the
indicated in the literature. This approach might be complemented with micro calcification
shape analysis and image segmentation techniques. The neuro fuzzy ANFIS model, utilized
in the mammogram ROI’s classification phase, reached a maximum accuracy rate of 99.75%
with Mini MIAS database and now can be tested with MIDAS database. This can be observed
in the results presented by Fernandes et al. (2010), when the sigmoidal membership function
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PSIGMFwas chosen, with the training algorithm in back propagation, employing small values
for epochs. The othermembership functions analyzed also showed satisfactory accuracy rates,
however theywere not the best ones. The cross validationmethod allowed a higher formalism
in the division of entry data (estimation, validation and test sets), which is necessary due
to the small quantity of images with calcifications available in the database Mini MIAS, to
prevent excessive training of the network and, consequently, a better generalization of the
system. The proposed system is available as a knowledge management tool. This allows the
dissemination of tacit and explicit knowledge of medical experts and their past experience in
the field, allowing still a better performance in the evaluation of routine exams by means of a
graphical tool.
6. Related work
The Mammographic Image Analysis Society (MIAS) is a database of digital mammograms
where the films are from the U.K. National Breast Screening Programme and they have
been digitised to 50 micron pixel edge with a Joyce-Loebl scanning microdensitometer, a
device linear in the optical density range 0-3.2 and representing each pixel with an 8-bit
word Suckling et al. (1994). The database contains 322 digitised films and it also includes
radiologist’s "truth"-markings on the locations of any abnormalities that can be present.
The database has been reduced to a 200 micron pixel edge and padded/clipped so that
all the images are 1024x1024 Suckling et al. (1994). The Digital Database for Screening
Mammography (DDSM) is a collaborative effort between Massachusetts General Hospital,
Sandia National Laboratories and the University of South Florida Computer Science and
Engineering Department. The database contains approximately 2,500 mammograms each
includes two images of each breast, along with some associated patient information (age at
time of study, ACR breast density rating, subtlety rating for abnormalities, ACR keyword
description of abnormalities) and image information. Images containing suspicious areas
have associated pixel-level "ground truth" information about the locations and types of
suspicious regions. The DDSM also provides software for accessing the mammogram
and truth images and for calculating performance figures for automated image analysis
algorithms Heath et al. (2001b).
7. Future work
7.1 Genotypes and phenotypes
The search of new genes of cancer and its epigenomics implications are the main areas
of future investigation. Discovering the human genomic variability and its complexes
phenotypes are the major obstacles and where the efforts will be concentrated. New image
processing algorithms and also new artificial intelligence methods will be used in order to
offer the physicians more technical support in the breast cancer treatment.
7.2 Breast cancer visual modeling
7.2.1 Motivation
Visual characteristics of human body components are highly relevant as an input for a variety
of decisions on health concerning activities. One can promptly access and eventually perform
adjustments on information upon some injury or physiological change through user-friendly
devices, as a valuable resource for therapeutic procedures and specialized training too.
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One should remark that visualization is supposed to convey information compatible with
viewer’s perception and cognition skills Agrawala et al. (2011). Visual modeling of cells
growth is an instance of data visualization that allows a fast information analysis for problem
solving. This kind of data processing more and more becomes an efficient way to support
decision-making. Visualization can be understood as a low-cost human cognitive process to
create an image about a domain space. It enables insights about some context, say, qualitative
and quantitative answers to existing problems and facts recognition that were previously not
possible Fayyad & Grinstein (2002) Konofagou (2004). Although visual models are able to
express just part of the features of the real object, they are enough informative and useful
for an effective subsequent decision process. Typical instances of lesion that require visual
information for treatment are cells abnormal growth that may constitute cancerous tissues
as a result of an evolutionary process with genetic mutations Beckmann et al. (1997) Evan
& Vousden (2001) Lux et al. (2006). Images provide relevant information about size and
tonalities irregularities that may express different kinds of existing lesions. The availability
of a non-invasive and inexpensive computational technique to model evolutionary process of
breast cancer thus becomes highly relevant. Hence one expects to develop models of breast
cancer, to recognize their properties, for supporting therapeutic processes and decisions, with
experimental validation in mammography clinics. Its results should be suitable for actual use
in units of health care.
7.2.2 Visual modeling
A visualization system is developed according to the following steps Agrawala et al. (2011).
Initially, the principles of design-oriented field of interest are identified. Then the algorithms
are developed to implement these principles. Afterwards the results are validated based
on users’ perception of visually modeled information. Segmentation is based on certain
characteristic features that are common to the pixels that should make up each segment. If
the image contains multiple objects with similar characteristics, as in the case of breast duct
anatomy, the approximate tones of pixels belonging to the object are a segmentation criterion.
After properly separated and identified the object or region, it becomes possible to capture
information that can be used for subsequent classification according known categories. Thus
it is essential to know all the properties that are necessary and sufficient to characterize an
object. The image of an object is a projection of a three-dimensional object on a plane. Through
the image we might infer the size of the projection of the object and thus estimate the size of
the object. The position of the object is useful for the activation of devices able to perform
any procedure directly on the scene, for example, microsurgery or application of medication.
Each property should be able to unambiguously characterize the objects belonging to different
classes and at the same time be able to accommodate all the variations that can occur for
objects belonging to the same class. The decision about membership of an object to some class
can be deterministic or probabilistic. In fact the value of a property in a set of standards can be
a random variable with estimated mean and standard deviation. So such decision is based on
the membership of the measured property in a pattern to a range of the known model. More
accurate procedures for statistical classification also consider the cost of misclassification,
which can be quite relevant, for example, at diseases diagnosis based on recognition of images
of tissue samples. Concerning therapeutic procedures it is often necessary to recognize tissues
with different textures, in order to assess the extent of changes in these tissues. This is the case
of analysis of the development of breast cancer. Project activities are shown in Figure 5.
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Fig. 5. Visual Modeling Project flow adapted from Guadagnin et al. (2011)
7.2.3 Expected results
One expects to have a system for visual modeling of evolutionary process of breast tumorous
tissues. It will also identify the main requirements for training professionals in monitoring
and management of patients supposed an appropriate use of computing resources.
7.2.4 Perspectives
Simulations could be used to advise patients and professionals about cancerous lesions
evolution as well as to examine evolving response to specific treatments. The model could
be also adjusted to simulate different cells mutation types Bankhead & Heckendorn (2007).
The amount of image processing and analysis applications in medical diagnosis is very
extent. Otherwise there are several other areas where these techniques are useful or even
indispensable too, for instance, in computer-assisted surgery, post-surgery follow-up or
therapy and monitoring of potentially dangerous evolution. Simulated images are helpful
for healing supported by computational processes and medical diagnosis, and applications of
telemedicine.
8. Conclusions
The MIDAS (Mammographic Image Database for Automated Analysis) is an innovative
database containing mammogram images covering a sample of Brazilian women population,
patient genome sequences data, open source image processing algorithms, open access and
open collaborative environment. After its initial tunning and legal procedures it will be
available to the Internet to worldwide access and collaboration. The MIDAS database project
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aims to enhance the scientific activity regarding breast cancer research among brazilian
women population and therefore raising the health prognosis.
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